A particular low risk for CIN2+ was observed in HPV test negative women indicating that a more differentiated routine screening protocol could be advocated for these women.
After expansion, these hVEC-EGFP reporter hESCs were differentiated and screened for the presence of cells with co-expression of EGFP and the pan-EC marker PECAM-1 (CD31) or endogenous VEC. Prior to differentiation to the endothelial lineage, hVEC-EGFP hESCs were grown to confluence on Matrigel-coated plate in mTeSR-1 medium as described above.
A major aim of this study was to evaluate if HPV testing would recover more CIN2+ than cytology alone and enable a more differentiated follow-up screening algorithm in selected groups of women.
The vast self-renewal and differentiation capacities of hESCs make them potential sources of large quantities of differentiated cells for drug screening and cell therapy.
Human embryonic stem cells can give rise to all cell types in the body and are a valuable tool to make differentiated cells for drug screening, predictive toxicology and potentially therapeutic applications.
These selected extracts were subjected to secondary screening whereby differentiated OBs from MC3T3E1 cells and chondrocytes from ATDC5 cells were cultured in the presence of the extracts for 3 days.
We screened all of the cell populations by FACS except for the differentiated NSC, which we screened by image to take advantage of the distinct morphological differences between neurons and non-neuronal cells.
This method provides the basis for functional genomic screens in differentiated cells, such as neurons and muscles, using RNAi or small molecules.
These cell lines can be differentiated in vitro and screened with whole genome oligonucleotide arrays to determine temporal profiles of gene expression.
From the imaging screen of differentiated NSC and subsequent hit verification by FACS, we predicted that CD184−/CD44−/CD15LOwould4+ would identify a population of neurons, whereas CD184+/CD44+ would identify a population of glia.
